Back to Search
Start Over
Developmental changes in glutamate receptor-activated translocation of protein kinase C in cerebellar granule neurons.
- Source :
-
Brain research. Developmental brain research [Brain Res Dev Brain Res] 1996 Jun 14; Vol. 94 (1), pp. 22-30. - Publication Year :
- 1996
-
Abstract
- Developmental changes in glutamate receptor agonist-produced enhancement of 4-beta-[3H]phorbol-12,13-dibutyrate binding ([3H]-PDBu binding), indicative of an intracellular translocation of protein kinase C (PKC), were investigated in cerebellar granule cells. Our observations demonstrate that the magnitude of glutamate-, NMDA-, and kainate-produced enhancement of PKC translocation was dramatically decreased between 2 and 12 DIV, whereas there was only a minor reduction in the corresponding response caused by the non-NMDA receptor agonist, AMPA. The maximally enhanced stimulation of PKC translocation caused by glutamate and NMDA was significantly reduced already at 4 DIV, whereas a significant reduction of the kainate-induced enhancement of [3H]PDBu binding was not observed until 8 DIV. Glutamate- and NMDA-induced responses were effectively blocked by the specific NMDA receptor antagonists MK-801 (1 microM) and APV (100 microM) as well as by the addition of Mg2+ into assay media. In contrast, the non-NMDA receptor antagonist, CNQX (10 microM), effectively blocked the kainate-induced enhancement of [3H]PDBu binding, but had no effect on the NMDA- and glutamate-induced stimulation of PKC translocation. The metabotropic glutamate receptor agonist, ACPD (up to 250 microM), had no effect on the translocation of PKC. Taken together, our data support the working hypothesis that the rapidly occurring changes in the glutamate receptor agonist-produced translocation of PKC are most likely due to a differential maturation of glutamate ionotropic receptor subtypes and/or to development-dependent alterations in mechanisms responsible for the coupling between the glutamate receptor subtypes and the activation of PKC translocation in cerebellar granule neurons.
- Subjects :
- 6-Cyano-7-nitroquinoxaline-2,3-dione pharmacology
Animals
Binding, Competitive physiology
Biological Transport physiology
Carcinogens pharmacology
Cells, Cultured chemistry
Cells, Cultured enzymology
Cerebellum growth & development
Cycloleucine analogs & derivatives
Cycloleucine pharmacology
Dizocilpine Maleate pharmacology
Excitatory Amino Acid Agonists pharmacology
Excitatory Amino Acid Antagonists pharmacology
Glutamic Acid pharmacology
Kainic Acid pharmacology
Magnesium pharmacology
N-Methylaspartate pharmacology
Neurotoxins pharmacology
Phorbol 12,13-Dibutyrate pharmacology
Rats
Rats, Sprague-Dawley
Tritium
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid pharmacology
Cerebellum chemistry
Cerebellum enzymology
Protein Kinase C metabolism
Receptors, Glutamate metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0165-3806
- Volume :
- 94
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Brain research. Developmental brain research
- Publication Type :
- Academic Journal
- Accession number :
- 8816273
- Full Text :
- https://doi.org/10.1016/0165-3806(96)00039-9